Data / Drug companies / Delmar Chemicals Inc
Delmar Chemicals Inc: 20 products in the FDA NDC directory, labeler code 11712
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Delmar Chemicals Inc (labeler code 11712) lists 20 products in the FDA National Drug Code Directory. By type: 20 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 16, 2026.
The request: Watch Delmar Chemicals Inc (FDA labeler code 11712): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 11712
- Products in commercial distribution
- 20
- Packages
- 20
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- March 12, 1982
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 20 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 20 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 20 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Brincidofovir | 11712-212 | Powder | Bulk ingredients | October 16, 2026 |
| Rilpivirine free base | 11712-824 | Powder | Bulk ingredients | October 10, 2025 |
| Rilpivirine free base | 11712-823 | Powder | Bulk ingredients | February 4, 2025 |
| Rilpivirine | 11712-822 | Powder | Bulk ingredients | November 11, 2024 |
| Tofacitinib citrate | 11712-895 | Powder | Bulk ingredients | February 19, 2021 |
| Succinylcholine chloride | 11712-832 | Powder | Bulk ingredients | August 28, 2006 |
| Succinylcholine chloride | 11712-830 | Powder | Bulk ingredients | August 28, 2006 |
| Tafamidis meglumine | 11712-829 | Powder | Bulk ingredients | October 4, 2005 |
| Fluorescein | 11712-375 | Powder | Bulk ingredients | August 25, 2004 |
| Fluorescein | 11712-373 | Powder | Bulk ingredients | August 25, 2004 |
| Fluvastatin sodium hydrate unmilled | 11712-399 | Powder | Bulk ingredients | August 14, 2002 |
| Fluvastatin sodium hydrate milled | 11712-398 | Powder | Bulk ingredients | August 14, 2002 |
| Fluvastatin sodium milled | 11712-397 | Powder | Bulk ingredients | August 14, 2002 |
| Fluvastatin sodium unmilled | 11712-396 | Powder | Bulk ingredients | August 14, 2002 |
| Pyrazinamide | 11712-815 | Powder | Bulk ingredients | May 11, 1999 |
| Methazolamide | 11712-530 | Powder | Bulk ingredients | December 1, 1996 |
| Methazolamide | 11712-007 | Powder | Bulk ingredients | August 1, 1990 |
| Pentamidine isethionate | 11712-790 | Powder | Bulk ingredients | July 23, 1986 |
| Pentamidine isethionate | 11712-788 | Powder | Bulk ingredients | July 23, 1986 |
| Esmolol hydrochloride | 11712-260 | Powder | Bulk ingredients | March 12, 1982 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.